A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients

Overview of attention for article published in Haematologica, February 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 3 news outlets
twitter: 12 X users

guideline: 2 clinical guideline sources

Readers on

mendeley: 189 Mendeley

So far, Altmetric has seen 5 news stories from 3 outlets.

The Management of Relapsed and Refractory Multiple Myeloma

Cancer Network, 26 Apr 2023

ABSTRACT The treatment of patients with relapsed and refractory multiple myeloma has become increasingly complex due to the…

Current Frontline Treatment of Multiple Myeloma

Cancer Network, 15 Jul 2022

ABSTRACT Treatment paradigms for management of newly diagnosed (ND) multiple myeloma have been evolving over the past 20 years…

Treatment Considerations for Transplant-Ineligible Multiple Myeloma

Cancer Network, 22 Apr 2021

Radowan A. Elnair, MD, and Sarah A. Holstein, MD, PhD, review literature regarding progress in the management of the transplant-i…

Frailty indexes fail in sorting elderly MM patients

Pediatric News , 09 Apr 2020

Despite the perceived benefits of their use in guiding treatment, frailty indexes were not reliable in differentiating elderly…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 1 additional news stories.